BRAINLIFE.ORG

Current Neuro-Oncology

Volume 26 Number 29
20 December 2024

Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 29, 20 December

Di Carlo D, Annereau M, Vignes M, Denis L, Epaillard N, Dumont S, Guyon D, Rieutord A, Jacobs S, Salomon V, Yoldjian I, Duperray F, Brunel L, Baiao X, Lemos F, Vauleon E, Capra M, Abbou S, Touat M, Sanson M, Gandemer V, De Carli E, Bourdeaut F, Hezam I, Vassal G, Grill J.
Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.
Eur J Cancer. 2024 Dec 11;216:115165. doi: 10.1016/j.ejca.2024.115165. PMID: 39700833. Compassionate use. ˍ

Jang HJ, Moon BJ, Park M, Joo B, Kim KH, Suh SH, Ahn SJ.
Transdural location as a predictor of recurrence in spinal cord meningiomas.
J Clin Neurosci. 2024 Dec 11;132:110975. doi: 10.1016/j.jocn.2024.110975? PMID: 39667314. Observational study˰ ˍ

Kakouri A, Chen Y, McCulley TJ.
Isolated Hemifacial Spasm as the Presenting Sign of Cerebral Glioblastoma.
Ophthalmic Plast Reconstr Surg. 2024 Dec 11. doi: 10.1097/IOP.0000000000002838. PMID: 39660646. Case report˰ ˍ

Li T, Zhao Z, Peng M, Zhang L, Wang C, Luo F, Zeng M, Sun K, Fang Z, Luo Y, Xie Y, Lv C, Wang J, Huang J-D, Zhou H, Sun H.
Multi-omics analysis reveals the interplay between intratumoral bacteria and glioma.
mSystems. 2024 Dec 11:e0045724. doi: 10.1128/msystems.00457-24. PMID: 39660865. Laboratory investigation. ˍ

Ozeki Y, Honda-Kitahara M, Yanagisawa S, Takahashi M, Ohno M, Miyakita Y, Kikuchi M, Nakano T, Hosoya T, Sugino H, Satomi K, Yoshida A, Igaki H, Kubo Y, Ichimura K, Suzuki H, Masutomi K, Kondo A, Narita Y.
Early progressive disease within 2 years in isocitrate dehydrogenase (IDH)-mutant astrocytoma may indicate radiation necrosis.
Jpn J Clin Oncol. 2024 Dec 11:hyae151. doi: 10.1093/jjco/hyae151. PMID: 39660448. Observational study˰ ˍ

Eldaya RW, Kaya D, Williams M, Calle S, Schellingerhout D.
Clinical and Imaging Features of Head and Neck Metastasis of High-Grade Glioma: A Single Center Case Series.
AJNR Am J Neuroradiol. 2024 Dec 12. doi: 10.3174/ajnr.A8521. PMID: 39667825. Case report˰ ˍ

Batista NM, Corrigan M, Chen JG.
Procedural sedation performed by pediatric critical care physicians for children undergoing daily radiation therapy is effective and safe.
Pediatr Hematol Oncol. 2024 Dec 13:1-9. doi: 10.1080/08880018.2024.2436496. PMID: 39673074. Observational study˰ ˍ

*Cheng S, McLaughlin JR, Brown MC, Rutka J, Bouffet E, Hawkins C, Cairney AE, Ranger A, Fleming AJ, Johnston DL, Greenberg M, Malkin D, Hung RJ.
Birth characteristics and the risk of childhood brain tumors: A case-control study in Ontario, Canada.
Int J Cancer. 2024 Dec 13. doi: 10.1002/ijc.35287. PMID: 39670564. Observational study˰ ˍ

Nagoshi N, Okubo T, Ozaki M, Suzuki S, Takeda K, Iga T, Matsumoto M, Nakamura M, Watanabe K.
Epidemiology and surgical outcomes of pediatric intradural spinal tumors: results from a retrospective series of patients operated in the first two decades of life.
Spinal Cord. 2024 Dec 13. doi: 10.1038/s41393-024-01052-y. PMID: 39672822. Observational study˰ ˍ

Ersöz CC, Berber H, Heper A.
"Grade 4 Astrocytoma vs Grade 4 Glioblastoma: Is there any clue in H&E?".
Int J Neurosci. 2024 Dec 16:1-6. doi: 10.1080/00207454.2024.2441994. PMID: 39686561. Observational study. ˍ

Negm L, Chung J, Nobre L, Bennett J, Fernandez NR, Nunes NM, Liu ZA, Komosa M, Aronson M, Zhang C, Stengs L, Bianchi V, Edwards M, Doherty S, Ercan AB, Cardenas MF, Macias M, Lueder MR, Ku M, Johnson M, Chang Y, Dimayacyac JR, Kraya AA, Guo Y, Naky S, Keith J, Gao AF, Munoz DG, Nguyen L, Tsang DS, Lim-Fat MJ, Das S, Shlien A, Ramaswamy V, Huang A, Malkin D, Villani A, Ertl-Wagner B, Levine A, Robinson GW, Pollock BH, Spector LG, Sei S, Dirks PB, Getz G, Nichols KE, Resnick AC, Wheeler DA, Das A, Maruvka YE, Hawkins C, Tabori U.
The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study.
Lancet Oncol. 2024 Dec 16:S1470-2045(24)00640-5. doi: 10.1016/S1470-2045(24)00640-5. PMID: 39701117. Observational study˰ ˍ

Westermann CR, Davidson TB, Waters K, Margol AS, Cheung CC.
Immune checkpoint inhibitors and endocrinopathies in pediatric brain tumor patients.
J Pediatr Endocrinol Metab. 2024 Dec 16. doi: 10.1515/jpem-2024-0243. PMID: 39680426. Observational study. ˍ

Chen H, Tan G, Zhong L, Hu Y, Han W, Huang Y, Liang Q, Szekeres D, Jiang H, Bharadwaj R, Smith SM, Wang HZ, Liu X.
MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy - a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis.
J Neurooncol. 2024 Dec 17. doi: 10.1007/s11060-024-04910-0. PMID: 39688766. Observational study. ˍ

Jang H, Moon S, Kwon HJ, Lee S, Choe G, Lee KS.
Genetic alteration analysis of non-pediatric diffuse midline glioma, H3 K27-altered.
Hum Pathol. 2024 Dec 17:105709. doi: 10.1016/j.humpath.2024.105709. PMID: 39701425. Observational study˰ ˍ

Zauderer MG, Jegede O, Jackman DM, Zwiebel JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Takebe N, Huang R, Carrillo JA, Brenner AJ, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U.
JCO Precis Oncol. 2024 Dec 18;8:e2400327. doi: 10.1200/PO.24.00327. PMID: 39693587. Interventional study˰ ˍ

Nysom K, Kilburn LB, Leary SES, Landi DB, de Vos-Kerkhof E, Perreault S, Witt O, Ziegler DS, Hernáiz Driever P, Franson AT, Baxter PA, Whipple NS, Kline C, Segal D, Jabado N, Bailey S, McCowage G, Hansford JR, Khuong-Quang DA, Gottardo NG, Hassall T, Han JW, Yalon Oren M, Chi SN, Qiu J, Da Costa D, Govinda Raju S, Manley P, Hargrave D.
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial.
Neuro Oncol. 2024 Dec 19:noae274. doi: 10.1093/neuonc/noae274. PMID: 39700439. Observational study. ˍ

Shibahara I, Shigeeda R, Watanabe T, Orihashi Y, Tanihata Y, Fujitani K, Handa H, Hyakutake Y, Toyoda M, Inukai M, Uemasu K, Shinoda M, Komai H, Sato S, Hide T, Kumabe T.
Radiological, clinical, and molecular analyses reveal distinct subtypes of butterfly glioblastomas affecting the prognosis.
Neurooncol Adv. 2024 Oct 23;6(1):vdae180. doi: 10.1093/noajnl/vdae180. PMID: 39687791. Observational study. ˍ

Henriksen OM, Maarup S, Hasselbalch B, Poulsen HS, Christensen IJ, Madsen K, Larsen VA, Lassen U, Law I.
Magnetic resonance imaging and o-(2-[¹⁸F]fluoroethyl)-l-tyrosine positron emission tomography for early response assessment of nivolumab and bevacizumab in patients with recurrent high-grade astrocytic glioma.
Neurooncol Adv. 2024 Oct 24;6(1):vdae178. doi: 10.1093/noajnl/vdae178. PMID: 39659835. Interventional study. ˍ

Dupere JM, Breen WG, Lucido JJ, Remmes NB.
Treatment of a Pregnant Patient With a Brain Tumor Using Pencil Beam Scanning Proton Therapy.
Adv Radiat Oncol. 2024 Nov 8;10(1):101673. doi: 10.1016/j.adro.2024.101673. PMID: 39660108. Case report. ˍ

*Lau ACK, Chan BLH, Yeung CSK, Li LF, Chan DTM, Lee MWY, Chan TKT, Ho JMK, Cheung KM, Tse TPK, Lau SSN, Chow JSW, Ko NMW, Loong HHF, El-Helali A, Poon WS, Woo PYM.
The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective study.
Neurooncol Adv. 2024 Nov 12;6(1):vdae194. doi: 10.1093/noajnl/vdae194. PMID: 39659837. Observational study. ˍ

*Sharifian A, Kazemian A, Farzin M, Amirkhani N, Farazmand B, Naderi S, Khalilian A, Pourrashidi A, Amjad G, Kolahdouzan K, Abyaneh R, Jablonska PA, Ghalehtaki R.
Postoperative NEOadjuvant TEMozolomide followed by chemoradiotherapy versus upfront chemoradiotherapy for glioblastoma multiforme (NEOTEM) trial: Interim results.
Neurooncol Adv. 2024 Nov 14;6(1):vdae195. doi: 10.1093/noajnl/vdae195. PMID: 39664679. Interventional study. ˍ

Henriksen OM, Muhic A, Lundemann MJ, Larsson HBW, Lindberg U, Andersen TL, Hasselbalch B, Møller S, Marner L, Madsen K, Larsen VA, Poulsen HS, Hansen AE, Law I.
Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma-A hybrid [¹⁸F]FET PET/MRI study.
Neurooncol Adv. 2024 Nov 18;6(1):vdae196. doi: 10.1093/noajnl/vdae196. PMID: 39664680. Observational study. ˍ

Shao Z, Yan H, Zhu M, Liu Z, Chen Z, Li W, Wang C, Zhang L, Zheng J.
The impact of the subventricular zone invasion types and MGMT methylation status on tumor recurrence and prognosis in glioblastoma.
Heliyon. 2024 Nov 20;10(23):e40558. doi: 10.1016/j.heliyon.2024.e40558. PMID: 39687126. Observational study. ˍ

*Kanamori M, Tsuzuki S, Shibahara I, Saito K, Shimoda Y, Tanaka K, Yamaguchi S, Natsumeda M, Matsutani T, Hanihara M, Nakada M, Kuroda JI, Matsuda M, Yoshimoto K, Yonezawa U, Sonoda Y, Takano K, Yonezawa H, Otani Y, Nakahara Y, Uchida M, Nonaka M, Mineharu Y, Kitamura Y, Yamashita S, Yamauchi T, Miyake Y, Deguchi S, Beppu T, Tamura K, Koizumi S, Hirose Y, Asano K, Hiruta R, Kinoshita M, Miyake K, Nakayama N, Inoue A, Ono T, Sasaki T, Akiyama Y, Fukami S, Yoshino A, Kawanishi Y, Asanome T, Yamaguchi T, Takahashi M, Yamasaki F, Arakawa Y, Narita Y.
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study.
Neurooncol Adv. 2024 Nov 28;6(1):vdae176. doi: 10.1093/noajnl/vdae176. PMID: 39659832. Observational study. ˍ

Xiao W, Li S, Tong Z, Li L, Zhang Y.
The Value of Diffusion Tensor Imaging in Differential Diagnosis of Embryonal Tumors Occurring in the Brainstem and Brainstem Gliomas in Pediatric Patients.
Pediatr Neurol. 2024 Nov 29;163:58-65. doi: 10.1016/j.pediatrneurol.2024.11.011. PMID: 39689574. Observational study˰ ˍ

*Gerrish AC, Malik L, Swain C, Thomas AG, Jaspan T, Dineen RA.
Diagnostic performance of axial T2-weighted MRI sequence for exclusion of brain tumour in paediatric patients with non-localizing symptoms.
Br J Radiol. 2024 Dec 2:tqae244. doi: 10.1093/bjr/tqae244. PMID: 39673436. Observational study˰ ˍ

Gheorghiu A, Brunborg C, Johannesen TB, Helseth E, Zwart JA, Wiedmann MKH.
Life-style and metabolic factors do not affect risk for glioma: a prospective population-based study (The Cohort of Norway).
Front Oncol. 2024 Dec 4;14:1471733. doi: 10.3389/fonc.2024.1471733. PMID: 39703841. Observational study. ˍ

Gallotti AL, Rossi M, Conti Nibali M, Sciortino T, Gay LG, Puglisi G, Leonetti A, Bruno F, Rudà R, Soffietti R, Cerri G, Bello L.
Neuro-Oncological Superiority of Supratotal Resection in Lower-Grade Gliomas.
Neuro Oncol. 2024 Dec 7:noae264. doi: 10.1093/neuonc/noae264. PMID: 39657577. Observational study˰ ˍ

Yang W, Ren S, Li Y, Cai Y, Peng X, Sun H, Chen J, Chai X, Zhang H, Zhu K, Ma W, Tian Y, Ge M.
A predictive model for cerebellar mutism syndrome based on lesion map in children with medulloblastoma.
Eur Radiol. 2024 Dec 10. doi: 10.1007/s00330-024-11264-8. PMID: 39658685. Observational study˰ ˍ